Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.

Higashihara E, Torres VE, Chapman AB, Grantham JJ, Bae K, Watnick TJ, Horie S, Nutahara K, Ouyang J, Krasa HB, Czerwiec FS, TEMPOFormula and 156-05-002 Study Investigators
Clin J Am Soc Nephrol. 2011 6 (10): 2499-507

PMID: 21903984 · PMCID: PMC3359559 · DOI:10.2215/CJN.03530411

MeSH Terms (20)

Adolescent Adult Antidiuretic Hormone Receptor Antagonists Benzazepines Disease Progression Female Glomerular Filtration Rate Hormone Antagonists Humans Japan Kidney Male Middle Aged North America Polycystic Kidney, Autosomal Dominant Prospective Studies Time Factors Tolvaptan Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links